TMSB10 and cancer: We found that both cancer cell migration and invasion were significantly decreased in the 2774 cells infected by Ad.TERT.Tβ10, in comparison with 2774 cells infected with Ad.TERT.LacZ and uninfected 2774 cells (Figure 3A).